ThePharmaLetter Profile Banner
The Pharma Letter Profile
The Pharma Letter

@ThePharmaLetter

Followers
25K
Following
177
Statuses
24K

Breaking news and analysis for the global pharmaceutical and biotechnology industries

London
Joined September 2009
Don't wanna be here? Send us removal request.
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
8 hours
@In8bio reports promising results for leukemia cell therapy
0
0
1
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
8 hours
@AnaptysBio rockets on rosnilimab data
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
8 hours
US, UK and Canada HTAs convene the Health Economics Methods Advisory
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
8 hours
@AbcuroInc closes $200 million Series C financing
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
8 hours
Beyond the deal: unlocking sustainable success in pharma M&A
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
Royalty Pharma inks R&D funding deal with @biogen
0
1
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
@abbvie expands oncology R&D with @xiliotx deal
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
Russia deepening localization in domestic pharma market
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
@biogen beats on earnings but guidance falls short
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
FDA approves @SpringWorksTx's Gomekli
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
@GileadSciences' rosy guidance sends shares upwards
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
Third Harmonic and Inventiva slash workforces
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
@VoyagerTx updates on SOD1 ALS gene therapy program
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
Two-year Bimzelx data demonstrate sustained disease control in HS
0
0
1
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
US states challenge Trump's NIH funding cuts
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
@AlloyTx and @pfizer in latest strategic collaboration
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
@Bridgebio wins EU approval for Beyonttra for ATTR-CM
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
@ellipsespharma in-licenses rights to immuno-oncology agent
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
Latest forecast sees obesity market reaching $173.5 billion sales in 7MM
0
0
0
@ThePharmaLetter
The Pharma Letter
@ThePharmaLetter
1 day
@Novartis to boost cardio pipeline with Anthos Therapeutics buy
0
0
0